minktherapeutics.com (INKT): Narxning prognoz qilingan daromadga nisbati

INKT (MiNK Therapeutics Inc.) - kompaniyaning tovar belgisi

MiNK Therapeutics, Inc. (INKT) onkologiya hamjamiyati ichida yuqori nufuzga ega bo'lib, ixtisoslashtirilgan fondlarni jalb qilmoqda. Massachusettsdagi ishlab chiqarish quvvatlari AQShga asoslangan CDMO zavodlari bilan to'ldirilgan, joriy daromadlar esa qattiq o'simtalar terapiyasining bozorga chiqarilishidan oldingi investitsiyalarga asoslangan. Kelgusidagi sotuvlar nisbati (forward price-to-sales ratio) kapital dinamikasini namoyish etadi, bunda 237.60 belgisi kompaniyaning kelgusidagi sotuvlariga nisbatan bozor kutganlari darajasini ko'rsatadi.

INKT MiNK Therapeutics Inc.: Bozor kapitallashuvining kelajakdagi daromadga nisbati 14.11.2026 - 18.11.2026 oraligʻida

MiNK Therapeutics, Inc. (INKT) kompaniyasining tahliliy kesimlari

- birja kapitallashuvi ma'lumotlari:
Kompaniyaning jamlanma tahlili:minktherapeutics.com INKT
MiNK Therapeutics, Inc tomonidan chiqariladigan mahsulotlar

Oldingi P/S koeffitsiyenti biznesning bozor qiymatini prognoz qilingan savdo hajmi bilan nisbatda baholaydi va bu kelajakdagi pul oqimlari uchun to'langan premiumni aniqlash imkonini beradi. Kutilayotgan narx-savdo koeffitsiyentini tahlil qilish orqali investor haddan tashqari qizigan aktivni sotib olish xavfini kamaytirishi mumkin, bu esa kapitalizatsiyasi hujayra terapiyasining noyobligiga va klinik sinovlar doirasidagi qat'iy FDA nazoratiga bog'liq bo'lgan MiNK Therapeutics, Inc. (INKT) uchun juda muhimdir.

Raqobatchilar tahlili

ImmunityBio Inc - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Immunocore Corp IMCR|JANX - Narxning prognoz qilingan daromadga nisbati|RCUS (arcusbio.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Zymeworks Biopharmaceuticals (ZYME) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Tango Pharma (TNGX)|Forvard narx/daromad multiplikatori IOVA|IMTX - Prognoz narxning daromadga nisbati|Forvard narx/daromad multiplikatori XNCR (Xencor Corp)|Narxning kutilayotgan daromadga nisbati CMPX|Forvard P/S multiplikatori REPL (Replimune)|Sotuvga nisbatan forvard narx LYEL|innate-pharma.com - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Pyxis Oncology|Compugen Limited (CGEN) - Narxning prognoz qilingan daromadga nisbati|IO Biotech, Inc. - Sotuvga nisbatan forvard narx|STRO (sutrobio.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori werewolftx.com|Narxning prognoz qilingan daromadga nisbati immixbio.com (IMMX)|ALXO: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori CUE (Cue Biopharma Inc.)|PDS Biotechnology (PDSB) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SONN - Narxning prognoz qilingan daromadga nisbati|MAIA Biotechnology, Inc. (MAIA) - Forvard narx/daromad multiplikatori|LIMN: Forvard P/S multiplikatori|LAVA Therapeutics N.V. (LVTX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori NXTC|Forvard P/S multiplikatori leaptx.com|Forvard P/S multiplikatori INTS|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Sensei Biotherapeutics, Inc.|Forvard P/S multiplikatori TOVX (Theriva Corp)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati gritstonebio.com (GRTS)|kinetabio.com - Forvard P/S multiplikatori|NexImmune (NEXI) - Forvard narx/daromad multiplikatori|turnstonebio.com (TSBX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vaccinex, Inc (VCNX)|Forvard narx/daromad multiplikatori HARP